Asbestos-related diseases: mesothelioma, lung cancer, asbestosis and pleural plaques

Mesothelioma is a rare and aggressive cancer of the mesothelium, the thin membrane that lines the lungs (pleura), the abdominal cavity (peritoneum), the heart (pericardium) or the testes (tunica vaginalis). Pleural mesothelioma accounts for about 80% of cases and peritoneal for most of the rest. The connection to asbestos is so strong that in a banned country, a confirmed mesothelioma diagnosis is effectively a marker of past asbestos exposure — so much so that many jurisdictions maintain a national mesothelioma register specifically to track historical exposure patterns.

The latency between first exposure and clinical mesothelioma is extraordinarily long, typically 30-40 years and sometimes up to 50. Symptoms are initially vague: persistent cough, shortness of breath, chest pain, fatigue, unexplained weight loss and pleural effusion (fluid around the lung). By the time these symptoms prompt medical investigation, the disease is usually advanced and often already metastatic.

Median survival from diagnosis remains poor — around 12 to 18 months with standard chemotherapy, and longer with newer immunotherapy regimens in selected patients. Surgical resection (extrapleural pneumonectomy or pleurectomy/decortication) is possible only in a minority of early-stage cases. Despite recent progress, mesothelioma remains one of the most lethal cancers, with a five-year survival rate below 10% in most national cancer registries.

Asbestos-related lung cancer is histologically identical to lung cancer caused by other agents such as tobacco smoke. The difference is the cause. IARC classifies asbestos as a Group 1 carcinogen for lung cancer, meaning the evidence that asbestos causes lung cancer in humans is considered definitive. All major histological subtypes — adenocarcinoma, squamous cell carcinoma, small cell and large cell — have been linked to asbestos exposure.

One of the most important findings in occupational epidemiology is the multiplicative interaction between asbestos and tobacco smoking. An asbestos worker who smokes has a lung cancer risk approximately 50 times higher than a person who neither smokes nor is exposed, compared with about 5 times for asbestos exposure alone and about 10 times for smoking alone. The two exposures do not merely add — they multiply. This is why smoking cessation is particularly urgent for any worker with a history of asbestos exposure.

Lung cancer typically has a latency of 15 to 30 years after first asbestos exposure, somewhat shorter than mesothelioma. Prognosis depends heavily on stage at diagnosis and on tumor molecular markers; advances in targeted therapy and immunotherapy have improved outcomes substantially over the past decade, but early-stage detection remains critical.

Asbestosis is a chronic, progressive fibrosis (scarring) of the lung parenchyma caused by inhaled asbestos fibers. Unlike the cancers, asbestosis is a non-malignant disease, but it is also irreversible and can be severely disabling or fatal. Asbestosis requires substantial cumulative exposure — far higher than the doses that produce mesothelioma — and is therefore primarily a disease of heavy occupational exposure over years or decades.

The classic asbestosis patient is a shipyard insulator, a boiler worker or an asbestos manufacturing employee from the 1960s or 1970s who handled raw fiber for most of a career. Symptoms emerge gradually as the scarring stiffens the lungs: shortness of breath on exertion, a persistent dry cough, clubbing of the fingertips and eventually respiratory failure. High-resolution CT imaging shows characteristic subpleural reticulation and honeycombing, often together with pleural plaques.

Asbestosis has no cure. Treatment is supportive — oxygen therapy, pulmonary rehabilitation, management of complications. The diagnosis is also an independent risk factor for lung cancer, so patients require ongoing surveillance.

Pleural plaques are discrete, white, thickened areas of the parietal pleura (the outer layer of the pleural membrane, attached to the chest wall). They are the most common radiological finding in asbestos-exposed individuals and are usually detected incidentally on chest X-rays or CT scans performed for other reasons. Plaques typically appear 20-30 years after first exposure and can follow relatively modest exposures, including some household and environmental exposures.

On their own, pleural plaques are not cancerous, they do not usually cause symptoms and they do not progress to mesothelioma. They are, however, an indelible marker of past asbestos exposure. For this reason, a positive finding of plaques on imaging triggers a full occupational history review and usually qualifies the affected person for compensation or pension schemes in jurisdictions that recognize asbestos-related conditions.

Diffuse pleural thickening is a related but more serious finding — a generalized scarring of the visceral pleura (attached to the lung itself) that can impair lung function. Unlike plaques, diffuse thickening can cause symptoms and progressive restriction, and it is associated with higher cumulative exposures.

Beyond the classic four, IARC has also concluded that asbestos exposure causes cancer of the larynx and ovary, and that there is limited evidence for an association with cancers of the pharynx, stomach and colorectum. The evidence base for these secondary sites is smaller because the cancers are more common overall, so an occupational signal is harder to detect, but the association is strong enough that asbestos is classified as a definite cause for larynx and ovary.

The relationship between asbestos dose and disease risk is different for each condition. For asbestosis, the relationship is clearly dose-dependent with an approximate threshold — you need a substantial cumulative exposure to develop the disease. For lung cancer, the risk rises roughly in proportion to cumulative exposure, with no clear threshold. For mesothelioma, the dose-response is essentially linear down to the lowest measurable exposures, with no safe level established.

This is the crux of modern asbestos regulation. Even a low-dose exposure — a single intense incident, a short period of DIY work, a brief construction-trade exposure — can potentially cause mesothelioma decades later. The probability is small but not zero. Risk is additive across all exposures during a lifetime, so avoiding every unnecessary exposure is the only rational strategy.

If you know or suspect you have been exposed to asbestos — occupationally, through DIY work, through a household contact, or environmentally — the appropriate medical response depends on the level and duration of exposure. For high, sustained occupational exposure, most countries offer or mandate ongoing surveillance: periodic chest X-ray or low-dose CT, lung function testing and clinical review. For lower or one-off exposures, systematic screening is generally not recommended because the benefit of early detection of mesothelioma is limited and screening imaging carries its own risks.

Any exposed person who develops persistent new respiratory symptoms — cough lasting more than three weeks, unexplained shortness of breath, chest pain, unexplained weight loss — should consult a physician and explicitly mention the asbestos exposure history. Early imaging may detect treatable stages of lung cancer and, occasionally, early mesothelioma.

Most European countries, Australia, Japan, Canada and parts of the United States have legal frameworks that recognize asbestos-related diseases as occupational diseases eligible for compensation. Asbestosis, mesothelioma, asbestos-related lung cancer, pleural plaques and diffuse pleural thickening are typically on the list, though the specific criteria vary by jurisdiction. Some jurisdictions have also established compensation funds for non-occupational victims — family members, DIY casualties and environmental exposure — especially in France (FIVA), Belgium (AFA), Italy and the Netherlands.

Anyone diagnosed with an asbestos-related disease should seek advice from a specialized occupational disease physician and from a legal advisor familiar with the national compensation framework. Claims often require documentation of exposure that may be 30-50 years old, which is why keeping records of past employment in construction, shipyards, insulation work or asbestos manufacturing is important.